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Abstract
Background: low fat-free mass has been related to high mortality in patients. This study evaluated the relationship between
body composition of healthy elderly subjects and mortality.
Methods: in 1999, 203 older subjects underwent measurements of body composition by bioelectrical impedance analysis,
Charlson co-morbidity index and estimation of energy expenditure through physical activity by a validated questionnaire.
These measurements were repeated in 2002, 2005 and 2008 in all consenting subjects. Mortality data between 1999 and
2010 were retrieved from the local death registers. The relationship between mortality and the last indexes of fat and fat-
free masses was analysed by multiple Cox regression models.
Results: women’s and men’s data at last follow-up were: age 81.1 ± 5.9 and 80.9 ± 5.8 years, body mass index 25.3 ± 4.6
and 26.1 ± 3.4 kg/m2, fat-free mass index 16.4 ± 1.8 and 19.3 ± 1.9 kg/m2 and fat mass index 9.0 ± 3.2 and 6.8 ± 2.0 kg/
m2. Fifty-eight subjects died between 1999 and 2010. The fat-free mass index (hazard ratio 0.77; 95% conﬁdence interval
0.63–0.95) but not the fat mass index, predicted mortality in addition to sex and Charlson index. The multiple Cox regres-
sion model explained 31% of the variance of mortality.
Conclusion: a low fat-free mass index is an independent risk factor of mortality in elderly subjects, healthy at the time of
body composition measurement.
Keywords: body composition, fat-free mass, fat-free mass index, mortality, older people
Introduction
Ageing has been associated with weight and body compos-
ition changes. Longitudinal studies have demonstrated a de-
crease in fat-free mass in healthy elderly subjects but
controversial results regarding fat mass [1–3]. These
changes in body composition may be detrimental to health.
For instance, a low fat-free mass has been associated with
reduced muscle strength, exercise tolerance, quality of life,
immune dysfunctions and increased hospital stays [4–6]. In
contrast, an increased fat mass, as found in obesity, has
been related to a higher risk of cardio-vascular diseases,
certain cancers, osteoarthritis and respiratory problems.
In clinical routine, body composition is often evaluated
in terms of body mass index (BMI = weight (kg)/height
(m)2). Several studies have demonstrated the impact of
BMI on mortality in older subjects. They described a
J-shaped or U-shaped relationship [4, 7–11] with the lowest
mortality occurring with a BMI around 23–28 kg/m2.
However, BMI gives only a crude estimation of body com-
position. Therefore, recent cohort studies evaluated the as-
sociation of fat and fat-free masses, generally adjusted for
body height, with mortality. Some found a relationship
between low fat-free mass and increased mortality risk in
elderly subjects [12–16], while others could not consistently
conﬁrm these ﬁndings [17, 18]. Similarly, some studies
described a positive relationship between obesity, especially
in the abdominal area, and increased risk of mortality [13,
15] but this was refuted by others [17–19]. These controver-
sies may be partly explained by the confounding impact of
physical activity and co-morbidities, which are often not
described in the aforementioned studies.
This study’s aims were to evaluate the relationship
between body composition and mortality, speciﬁcally in
healthy white community-dwelling subjects≥65 years, while
taking into account physical activity and co-morbidity. We
hypothesised that a low fat-free mass and a high fat mass
were associated with a higher risk of mortality, once
adjusted for co-morbidities and physical activity.
Methods
Subjects and study design
This longitudinal study includes 203 healthy white subjects
aged≥65 years, who were recruited through advertisements
in newspapers and leisure clubs in 1999. We excluded sub-
jects with decompensated heart, lung, kidney or liver
failure, symptomatic neurological disorders, known active
cancer or chronic infectious diseases, signiﬁcant mental im-
pairment, involuntary weight loss or gain over 3% in the
last 3 months, and hospitalisation in the last 6 months [1].
The volunteers were sent an invitation letter for the
Geneva University Hospital, a health questionnaire and a
physical activity questionnaire, and were asked not to
perform any strenuous physical activity and to drink at least
1 l of liquid the day before coming to the hospital. On the
study day, the volunteers reviewed the questionnaires with
the investigators and underwent a measurement of body
composition by bioelectrical impedance analysis (BIA)
between 7:30 and 9:00 am.
The questionnaires and BIA measurements were repeated
in 2002, 2005 and 2008 in all included subjects who could
be reached by phone and consented to participate. None of
the subjects clinically showed signs of oedema or ascites.
Mortality data between January 1999 and December 2010
were retrieved from ofﬁcial sources detailed thereafter. The
relationship between mortality and the last available body
composition of each subject was evaluated, while taking into
account health status and physical activity.
All subjects signed an informed consent. The Geneva
University Hospital Ethical Committee approved the
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protocol. This study was supported by the Public
Foundation Nutrition 2000Plus.
Anthropometry and body composition
Body height was measured to the nearest 0.5 cm with a
height gauge and body weight to the nearest 0.1 kg on a
balance beam scale (Seca, Germany), with the subject in
underclothing and without shoes, on the day of body com-
position measurement.
Body composition was measured by BIA. After cleaning
the skin with 70% alcohol, adhesive electrodes (3M Red
Dot, *M Health Care, Borken, Germany) were placed on
the right hand and foot, the subject lying on his back as
generally described. A Xitron 4000B device (Xitron
Technologies, San Diego, CA, USA) applied an alternating
electrical current of 50 kHz and 0.8 mA to these electrodes.
Resistance and reactance were measured and fat-free mass
was calculated by the following equation [20], validated
against dual-energy X-ray absorptiometry (DXA) in elderly
subjects [21]:
Fat-free mass (kg) =− 4.104 + (0.518 × height2/
R) + (0.231 × weight) + (0.13 × reactance) + (4.229 × sex),
where sex = 1 for men and 0 for women.
Fat-free and fat-free masses were normalised for height
by calculating indexes of fat and fat-free masses (fat mass
index (FMI) = fat mass (kg)/height (m)2; fat-free mass
index (FFMI) = fat-free mass (kg)/height (m)2).
In order to determine whether there is a cut-off of body
composition associated with an increased risk of mortality, we
performed four dichotomous categorisations of FFMI,
according to our previously published age- and gender-speciﬁc
percentiles of FFMI [22] (< or ≥ percentile 10, < or ≥25, <
or ≥50, < or ≥75) and four dichotomous categorisations of
FMI (< or ≥ percentile 10, < or ≥25, < or ≥50, < or ≥75).
Health questionnaire
The health questionnaires allowed for the calculation of the
Charlson co-morbidity index, which reports 19 medical
conditions weighted 1–6 by severity and whose total score
ranges from 0 (no co-morbidity) to 37 [23]. It is strongly
associated with mortality and disability [24].
Physical activity questionnaires
The physical activity questionnaire was a frequency question-
naire encompassing leisure and non-leisure physical activities
of the previous week, validated against heart rate monitoring
in subjects aged 35–69 years [25]. The frequency and dur-
ation of each physical activity were multiplied by the body
weight and the metabolic equivalent [26] of the analysed ac-
tivity to obtain weekly energy expenditure. Analysed activities
were all activities besides sleeping. The energy expenditures
of the different activities were added up and divided by 7 to
obtain daily energy expenditure by physical activity.
Mortality
Mortality was searched for in all subjects who could not be
reached by phone at any one of the follow-up visits.
For the subjects living in the Geneva area, mortality
data from January 1999 to December 2010 were retrieved
from the ofﬁcial death website and the registry ofﬁce from
the Geneva area. For the subjects living in the Lausanne
area (n= 8), the investigators checked with the administra-
tion of the cities they were living in at the last follow-up,
whether they were still alive by December 2010. As mortal-
ity data could not be retrieved for the subjects living in
France (n = 10), they were excluded from the analysis.
Statistics
The normality of the distribution of continuous data was
veriﬁed. Data between alive and deceased subjects were
compared with unpaired t-tests.
Univariate Cox regressions (Model 1) assessed the rela-
tionship between mortality and sex, the last available age,
BMI, FMI and FFMI, physical activity and Charlson index.
The Cox regressions between mortality and physical activity
and between mortality and Charlson index did not respect
log-linearity. This led to a categorisation of physical activity
as < or ≥ the median value of energy expenditure through
physical activity, i.e. 1,533 kcal/day for men and 1,317
kcal/day for women. Charlson index was categorised as 0
if the subject was healthy or 1 if his score was >0.
Univariate Cox regressions also assessed the association
between mortality and the percentile categories of FFMI
and FMI that take into account age and gender by deﬁn-
ition. Kaplan–Meier curves illustrated survival according to
percentile categories of body composition.
Multiple Cox regression models determined the associ-
ation of mortality with age- and sex-adjusted body compos-
ition, physical activity and Charlson index (Model 2). A
third model of multiple Cox regression (Model 3) evaluated
the relationship between mortality and the following predic-
tors: age, sex, FMI and FFMI, categories of physical activity
and of Charlson index. The empirical method of Harrell
states a necessity of at least 10 observations per predictor
in multivariable prognostic models [27]. In our study, we
observed a total of 58 deaths, and used six predictors of
mortality, which followed the rule of Harrel. For each Cox
model, the hazard proportional assumptions were checked
by the proportional-hazards assumption test. We calculated
hazard ratios (HRs) with their 95% conﬁdence intervals
and the adjusted R-squared (R2), corresponding to the vari-
ance of mortality explained by each variable or model.
Signiﬁcance was set at P < 0.05. Statistical analyses were
performed with Stata software version 12 (TX, USA).
Results
Characteristics of the subjects at last follow-up are shown
in Table 1. Their mean age was greater than 80 years.
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Compared to population-speciﬁc norms of subjects aged
75–84 years, their mean FFMI was between 50th and 75th
percentile and their mean FMI between 25th and 50th per-
centile for women and 50–75th percentile for men [26].
Of the 203 included subjects, 58 died during the 11
years of follow-up, with a higher death rate in men than in
women (37.6% versus 19.6%, P = 0.005). Mean time until
death was 1,980 ± 1,051 days in women and 1,176 ± 855
days in men (P = 0.003) and, until end of follow-up of the
people who were alive, 1,690 ± 1,204 days in women and
1,460 ± 1,089 days in men (P = ns). Men and women who
had died had a lower FFMI, physical activity and a higher
Charlson score than the subjects who were still alive.
Univariate Cox regressions for the prediction of mortal-
ity (Table 2, Model 1) were signiﬁcant for BMI, FFMI,
FMI and physical activity. Regarding dichotomous percent-
ile categories of body composition, FFMI was below per-
centile 10, 25, 50 and 75, in 17, 42, 85 and 131 subjects,
respectively. Only FFMI < percentile 10 (HR 2.05, CI 1.03–
4.05, P = 0.040) predicted mortality. The other percentile
categories of FFMI and FMI were not associated with mor-
tality. Kaplan–Meier curves (Figure 1) illustrate that a
FFMI < percentile 10 was associated with a lower survival
than a FFMI≥ percentile 10.
Cox regressions adjusted for age and gender (Table 2,
Model 2) were signiﬁcant for the FFMI and the Charlson
category. The multiple Cox regression model including age,
sex, FFMI, FMI, physical activity and Charlson index
(Table 2, Model 3) was signiﬁcant for sex, FFMI and
Charlson index and explained 31% (adjusted R2) of the
variance of mortality. Replacing FFMI and FMI by BMI
decreased the adjusted R2 to 27%, which highlights the im-
portance of body composition compared to BMI.
Discussion
This study found that, in community-dwelling subjects≥65
years, FFMI is associated with mortality when taking into
account co-morbidities, age and gender. Body composition
was measured in relatively healthy subjects as shown by the
low Charlson index at the time of measurement. The
Kaplan–Meier curves suggest that the cut-off associated
with increased risk of mortality is an FFMI < percentile 10,
based on previously published normative values. This cor-
responds to a FFMI <16.9 and <13.7 kg/m2 for men and
women with a mean age of 80 years, respectively [22]. No
association between weight, BMI, FMI and mortality could
be found in this population.
Three studies reported a negative relationship between
total body fat-free mass and mortality in community-dwell-
ing subjects, as in our study. An impressive Danish study
included over 50,000 men and women aged 50–64 years
who underwent BIA measurements and were followed for
a median time of 5.8 years [13]. Exclusion criterion was
active cancer. The authors used a BIA equation validated
against a four-compartment model based on total body po-
tassium counting and dilutometry in Danish subjects aged
35–65 years. They showed that a low FFMI (<19.7 and
16.6 kg/m2 in men and women, respectively) predicted
mortality. Their cut-offs of FFMI associated with mortality
were higher than those in our study but their subjects were
younger and from another geographical background.
Another study included over 10,000 US men aged 20–75
years at baseline and participating in the NHANES I and
II Surveys [28]. Their body composition was measured by
skinfold thickness and was expressed as indexes. Mean
follow-up time was 14.6 years for NHANES I and 12.9
years for NHANES II. The authors demonstrated a nega-
tive relationship between FFMI and mortality but did not
analyse speciﬁcally subjects≥65 years, did not mention the
ethnicity of their subjects, nor included women and used
skinfold thickness which is known for its interobserver
variability. Finally, fat-free mass/height was associated with
mortality in 1,413 Chilean people aged 74.3 ± 5.6 years at
time of body composition measurement by DXA and fol-
lowed for a median of 1,594 days [14]. The authors had
excluded subjects with cancer, cardiac or renal failure. Our
study demonstrates the same association but also takes into
account co-morbidities.
In two studies, physical activity was evaluated by ques-
tionnaires. In the ﬁrst one, 2,819 Danish subjects aged 35–
65 years and without previous coronary heart disease,
stroke or cancer, underwent a measurement of body
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1. Characteristics at last follow-up of subjects alive versus deceased (mean ± SD)
Women Men
Total (n= 102) Alive (n= 82) Deceased (n= 20) Total (n= 101) Alive (n= 63) Deceased (n= 38)
Age (years) 81.1 ± 5.9 80.8 ± 0.7 82.6 ± 0.9 80.9 ± 5.8 79.9 ± 0.7 82.5 ± 1.0*
Height (cm) 158.2 ± 5.6 158.5 ± 0.6 157.3 ± 1.2 168.9 ± 7.7 169.5 ± 0.9 167.9 ± 1.5
Weight (kg) 63.5 ± 12.9 64.3 ± 1.4 60.2 ± 3.0 74.4 ± 10.8 76.6 ± 1.3 70.8 ± 1.7*
BMI (kg/m2) 25.3 ± 4.6 25.6 ± 0.5 24.3 ± 1.1 26.1 ± 3.4 26.7 ± 0.4 25.1 ± 0.5*
FFMI (kg/m2) 16.4 ± 1.8 16.5 ± 0.2 15.6 ± 0.4* 19.3 ± 1.9 19.7 ± 0.2 18.6 ± 0.3*
FMI (kg/m2) 9.0 ± 3.2 9.0 ± 0.3 8.7 ± 0.8 6.8 ± 2.0 7.0 ± 0.2 6.5 ± 0.3
Physical activity (kcal/day) 1,392 ± 563 1,470 ± 577 1,067 ± 365* 1,534 ± 545 1,641 ± 537 1,357 ± 516*
Charlson index 1.8 ± 2.5 1.5 ± 0.3 2.9 ± 0.6* 3.0 ± 2.8 2.5 ± 0.3 3.8 ± 0.5*
BMI, body mass index; FFMI, fat-free mass index; FMI, fat mass index.
*P < 0.05 (unpaired t-test) between deceased and alive subjects.
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composition by BIA and a questionnaire on leisure-time ac-
tivity [18]. Mortality was assessed on an average of 13.6
years later. The authors stratiﬁed the subjects according to
physical activity and found a negative relationship between
FFMI and mortality in active men but no relationship in
women. The second study included almost 10,000 US men
and women, stratiﬁed by gender and age categories (18–64
years, 65–75 years and >75 years). FFMI determined by
BIA and adjusted for physical activity, was associated with
mortality only in men aged 65–75 years [17]. None of
these studies can be consistently compared with ours as the
variables entered in the regression models differed but all
agree on some link between FFMI and survival.
The association of fat mass and mortality in elderly
subjects is unclear. The aforementioned studies described
an increased risk of mortality with high FMI [13, 28] as
well as with weight and fat loss [29]. Allison et al. [30]
found a decreased risk of mortality with fat mass loss.
These apparently contradictory results regarding the rela-
tionship between fat mass loss and mortality may be
explained by the wide age range of the subjects, the
methods of body composition measurement used, the
consideration of confounding factors as co-morbidities
and physical activity, and possibly by a non-linear rela-
tionship of body composition changes and mortality. In
our study, FMI did not contribute to mortality. Our
elderly subjects may have been healthier at time of body
composition measurement than in the other studies,
leading to an absence of impact of FMI on mortality.
Interestingly, some papers described an increased risk of
mortality in elderly subjects with a BMI below 18.5 kg/
m2 and ≥35 kg/m [2, 4, 7, 8, 10]. The BMI range of our
subjects was 17–36 kg/m2, which indicates that only a
small percentage of subjects had a BMI associated with
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2. Multiple Cox regression model investigating the relationship of mortality and body composition
Univariate Cox regression (Model 1) Multiple Cox regression (Model 2) Multiple Cox regression (Model 3)
HR 95% CI P Adjusted R2 HR 95% CI P Adjusted R2 HR 95% CI P Adjusted R2
Age (years) 1.07 1.03–1.11 0.001 0.109 – – – – 1.03 0.99–1.08 0.170 0.312
Sex (man) 2.72 1.57–4.68 0.001 0.130 – – – – 6.61 2.35–18.6 ≤0.001
BMI (kg/m2) 0.96 0.90–1.03 0.252 0.001 0.95 0.88–1.02 0.207 0.093 – – –
FFMI (kg/m2) 1.00 0.90–1.12 0.927 0.001 0.81 0.69–0.97 0.018 0.263 0.77 0.63–0.95 0.015
FMI (kg/m2) 0.92 0.84–1.01 0.091 0.021 0.99 0.89–1.11 0.900 0.206 1.10 0.95–1.29 0.193
Physical activity
<Median value (kcal/day) 1.00 – – – 1.00 – – – 1.00 – –
≥Median value (kcal/day) 0.58 0.33–1.00 0.052 0.031 0.68 0.38–1.20 0.186 0.223 0.74 0.41–1.35 0.325
Charlson index
Healthy 1.00 – – – 1.00 – – – 1.00 – –
Diseased 2.74 1.60–4.70 ≤0.001 0.133 1.97 1.10–3.50 0.021 0.257 1.96 1.10–3.49 0.022
BMI, body mass index; FFMI, fat-free mass index; FMI, fat mass index.
Model 1: univariate Cox regression.
Model 2: same as Model 1 but with each parameter adjusted for age and gender.
Model 3: model including age, sex, FFMI, FMI, physical activity and Charlson index.
Figure 1. Kaplan–Meier curves illustrate the survival according to percentiles of FFMI. Figures A and B represent Kaplan–
Meier survival curves of subjects with a FFMI < percentile 10 (dotted line; n = 7) versus those with a FFMI ≥ percentile 10
(plain line; n = 138) (A) and the subjects with a FFMI < percentile 25 (dotted line; n = 23) versus those with a FFMI ≥ percentile
25 (plain line; n = 122) (B). P indicates the degree of signiﬁcance between the binary data, by log-rank test.
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increased mortality and also explains the absence of rela-
tionship between BMI and mortality in our study.
The limitation of our study is the report of only 58
deaths during follow-up, which precludes analysis stratiﬁed
by gender. Our subjects had a BMI of 17–36 kg/m2, im-
plying that our results need conﬁrmation in subjects with
higher and lower BMI. We did not look at the impact of
body composition changes on mortality and it would be
interesting to evaluate whether they are better predictors of
mortality than absolute values. Indeed, a loss of fat mass
and fat-free mass has been associated with mortality [29].
Conclusion
Our study showed that FFMI is an independent risk factor
of mortality in subjects ≥65 years, healthy at the time of
body composition measurement. Future studies should
evaluate whether body composition changes better predict
mortality than single values of FFMI and FMI, and
whether this association is stronger in diseased than in
healthy subjects.
Key points
• Longitudinal study.
• Healthy patients at the time of body composition
measurement.
• Fat-free mass predicts mortality.
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Clinical benefits of oral nutritional
supplementation for elderly hip fracture
patients: a single blind randomised
controlled trial
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Abstract
Background: malnutrition is an important risk factor for poor outcome in patients recovering after hip fracture surgery.
This study aimed to investigate the clinical, nutritional and rehabilitation effects of an oral nutritional supplementation
(ONS) in an inpatient rehabilitation setting.
Methods: this was an observer-blinded randomised controlled trial of elderly post-surgical proximal femoral fracture
patients. A ready-to-use oral liquid nutritional supplementation (18–24 g protein and 500 kcal per day) in addition to
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